StockStory.org on MSN
Myriad Genetics (MYGN) stock trades up, here is why
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 22.2% in the pre-market session after ...
Labcorp Holdings Inc. LH has agreed to acquire the prenatal health testing business of Myriad Genetics Inc. MYGN in an ...
Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH) ...
Transaction value: $210 million cash payment plus the inventory value of the prenatal business at closing, as per the filing.
If you had looked at Myriad Genetics in October 2025, seen bullish talk about genomics, AI and precision medicine, then ...
Following the news, Myriad Genetics shares are surging 29.10% to $5.45. Labcorp provides laboratory services to doctors, hospitals, and pharmaceutical companies, while Myriad Genetics develops and ...
This study presents RovHer, a heritability-optimized scoring method for estimating the functional impact of rare variants, which is applied to the UK Biobank to demonstrate its ability to enrich for ...
Opus is developing gene therapies for inherited retinal diseases, including OPGx-BEST1 for Best disease and OPGx-LCA5 for ...
Scientists accidentally discovered a microscopic organism with a genetic code that breaks a rule researchers thought was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results